Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID-19
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 45 years
- Gender
- Both males and females
Description
Before inclusion, the participants will be able to pre-register to the event via a website. They will get an appointment for an inclusion visit at the Accor Arena (Paris Bercy, France). During 3 days (from D-3 to D-1), participants with a registration will come to the Accor Arena to have a rapid Sar...
Before inclusion, the participants will be able to pre-register to the event via a website. They will get an appointment for an inclusion visit at the Accor Arena (Paris Bercy, France). During 3 days (from D-3 to D-1), participants with a registration will come to the Accor Arena to have a rapid Sars-Cov-2 antigen test (results in 15 min). If the test is positive, the participant will be contacted and managed by the medical team in charge of the national strategy for positives cases. People with a negative test will be included and randomized : Two kits with tube for collecting saliva samples (for D0 and D7) will be given to each participant at this visit People randomized in the experimental group will receive their concert ticket at a later date. At Day 0, people randomized in the experimental group, will come to the Accor Arena with their ticket to participate in the concert. At the entrance, they should give their D0 saliva sampling kit. The people randomized in the control group will stay at home and will send their D0 saliva sample by post mail. At Day 7 (±1 day) all the participants must return their D7 saliva sampling kit via post mail
Tracking Information
- NCT #
- NCT04872075
- Collaborators
- PRODISS
- WEEZEVENT
- Investigators
- Principal Investigator: Constance DELAUGERRE, PhD Assistance Publique - Hôpitaux de Paris